News | September 16, 2025
Alembic Pharmaceuticals receives EIR for API - I and API - II facility located at Panelav
The inspection was carried out between May 26, 2025 and May 31, 2025
The inspection was carried out between May 26, 2025 and May 31, 2025
The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
Drug Hunter is already relied upon by researchers at more than 200 leading organizations, including Eli Lilly, Biogen, Merck KGaA, Isomorphic Labs, Deerfield Management
This strategic collaboration represents the third clinical trial under Senhwa’s five-year NCI-sponsored cancer research program
RN3161 is engineered to reduce fat while preserving lean mass, setting it apart from current treatment options
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
Late-breaking data presented at WCLC highlight significant and sustained improvements in overall survival, including more than doubling five-year survival rates compared to chemotherapy alone
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
Element5’s Agentic AI platform will be integrated with the HCHB EHR
Subscribe To Our Newsletter & Stay Updated
